USG Announces Keynote Speakers for its III International Conference on Vaccines Research & Development in Washington DC
PLANO, TEXAS, UNITED STATES OF AMERICA, September 28, 2017 /EINPresswire.com/ -- United Scientific Group (USG) recently announced its world-class lineup of speakers, sponsors and exhibitors for III International Conference on Vaccines Research & Development (Vaccines R&D 2017). This year’s event will be held November 13-15 at the Sheraton Reston Hotel, Reston located within the Washington, D.C. metropolitan area with a gathering of over 250 prominent researchers from academia, industry and government agencies from over 20 countries around the world.
“After two successful annual meetings in 2015 and 2016 at Baltimore, MD, United States and Cartagena, Colombia, respectively, we are excited and pleased again to see that many influential leaders have committed to speak at Vaccines R&D-2017. Their experience and leadership in the international vaccine market will allow for critical and insightful discussions at the venue” commented Dr. Suds Yakkanti, Associate Vice President, United Scientific Group.
I. Keynote speakers to kick-off Vaccines R&D-2017: On November 13, the Vaccines R&D-2017 general session will feature keynote address from the stalwarts in the field to stimulate productive thinking and scientific exchange with ground breaking vaccine research and discussion of the challenges and future of immunization.
Speakers include:
Jay A. Berzofsky, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Nancy Sullivan, Biodefense Research Section, NIAID, NIH, Bethesda, MD, USA
Roy Curtiss, III, Department of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA
Peter L. Nara, Biological Mimetics, Inc., Frederick, MD, USA
Manuel Elkin Patarroyo M, Foundation Institute of Immunology of Colombia – FIDIC, Bogotá DC – Colombia, SA
Stephen L. Hoffman, Sanaria Inc., Rockville, MD, USA
Michael G. Hanna, Vaccinogen Inc., Baltimore, MD, USA
Odile Leroy, European Vaccine Initiative, Germany
Pierre A. Morgon, MRGN Advisors, Switzerland
David B. Weiner, The Wistar Institute, Philadelphia, PA, USA
II. The long road to an HIV vaccine _ Symposium: In view of the overwhelming importance of the HIV pandemic and the huge R&D efforts currently underway to develop an HIV vaccine, we believe it would be justified to devote a full day (November 14) symposium on HIV vaccine development with the Title: “The long road to an HIV vaccine”
Speakers include:
Susan Zolla-Pasner, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Hanneke Schuitemaker, Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines and Prevention, The Netherlands
Louis Picker, Oregon Health & Science University, OR, USA
Neil S. Greenspan, Case Western Reserve University, Cleveland, OH, USA
Marc H V Van Regenmortel, University of Strasbourg, France
These are keynote speakers among more than 20 high profile speakers from both academia and industry who will address the symposium.
III. Special session on vaccine regulation: A special session on Vaccine Regulation with a theme “Challenges for registration of vaccines at global level” is scheduled to discuss and share the regulatory aspects in the vaccine evaluation and approval process.
Speakers include:
Nora Dellepiane, Serum Institute of India Pvt. Ltd, India
Kelsy Hofman, CBER/FDA
Bartholomew Dicky Akanmori, WHO/Afro
In this scientific gathering, one can attend keynote and featured sessions led by over 150 experts focusing on key areas like: cancer and immunotherapy, emerging and re-emerging diseases, influenza and other respiratory diseases, bioprocessing and manufacturing, clinical trials, HIV, passive vaccines, therapeutic vaccination, veterinary immunization, vaccine production technologies, bioprocessing & manufacturing, and partnerships.
The lead sponsors and exhibitor for the Vaccines R&D-2017 are Mucosis, Sanofi Pasteur and GenScript respectively.
To register or learn more about the conference, PS: http://www.unitedscientificgroup.com/conferences/vaccines/
About Organizer:
United Scientific Group (USG), an expert-driven initiative led by the editors’ association and the advisory board which includes academicians, researchers, and industry leaders across various fields of research. USG provides a broad range of services in the fields of science and technology including publishing, conducting world class scientific events, and holding highly interactive and productive world forums. For more information, please visit: http://unitedscientificgroup.com/
“After two successful annual meetings in 2015 and 2016 at Baltimore, MD, United States and Cartagena, Colombia, respectively, we are excited and pleased again to see that many influential leaders have committed to speak at Vaccines R&D-2017. Their experience and leadership in the international vaccine market will allow for critical and insightful discussions at the venue” commented Dr. Suds Yakkanti, Associate Vice President, United Scientific Group.
I. Keynote speakers to kick-off Vaccines R&D-2017: On November 13, the Vaccines R&D-2017 general session will feature keynote address from the stalwarts in the field to stimulate productive thinking and scientific exchange with ground breaking vaccine research and discussion of the challenges and future of immunization.
Speakers include:
Jay A. Berzofsky, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Nancy Sullivan, Biodefense Research Section, NIAID, NIH, Bethesda, MD, USA
Roy Curtiss, III, Department of Infectious Diseases & Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA
Peter L. Nara, Biological Mimetics, Inc., Frederick, MD, USA
Manuel Elkin Patarroyo M, Foundation Institute of Immunology of Colombia – FIDIC, Bogotá DC – Colombia, SA
Stephen L. Hoffman, Sanaria Inc., Rockville, MD, USA
Michael G. Hanna, Vaccinogen Inc., Baltimore, MD, USA
Odile Leroy, European Vaccine Initiative, Germany
Pierre A. Morgon, MRGN Advisors, Switzerland
David B. Weiner, The Wistar Institute, Philadelphia, PA, USA
II. The long road to an HIV vaccine _ Symposium: In view of the overwhelming importance of the HIV pandemic and the huge R&D efforts currently underway to develop an HIV vaccine, we believe it would be justified to devote a full day (November 14) symposium on HIV vaccine development with the Title: “The long road to an HIV vaccine”
Speakers include:
Susan Zolla-Pasner, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Hanneke Schuitemaker, Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines and Prevention, The Netherlands
Louis Picker, Oregon Health & Science University, OR, USA
Neil S. Greenspan, Case Western Reserve University, Cleveland, OH, USA
Marc H V Van Regenmortel, University of Strasbourg, France
These are keynote speakers among more than 20 high profile speakers from both academia and industry who will address the symposium.
III. Special session on vaccine regulation: A special session on Vaccine Regulation with a theme “Challenges for registration of vaccines at global level” is scheduled to discuss and share the regulatory aspects in the vaccine evaluation and approval process.
Speakers include:
Nora Dellepiane, Serum Institute of India Pvt. Ltd, India
Kelsy Hofman, CBER/FDA
Bartholomew Dicky Akanmori, WHO/Afro
In this scientific gathering, one can attend keynote and featured sessions led by over 150 experts focusing on key areas like: cancer and immunotherapy, emerging and re-emerging diseases, influenza and other respiratory diseases, bioprocessing and manufacturing, clinical trials, HIV, passive vaccines, therapeutic vaccination, veterinary immunization, vaccine production technologies, bioprocessing & manufacturing, and partnerships.
The lead sponsors and exhibitor for the Vaccines R&D-2017 are Mucosis, Sanofi Pasteur and GenScript respectively.
To register or learn more about the conference, PS: http://www.unitedscientificgroup.com/conferences/vaccines/
About Organizer:
United Scientific Group (USG), an expert-driven initiative led by the editors’ association and the advisory board which includes academicians, researchers, and industry leaders across various fields of research. USG provides a broad range of services in the fields of science and technology including publishing, conducting world class scientific events, and holding highly interactive and productive world forums. For more information, please visit: http://unitedscientificgroup.com/
Mr. Venky and Dr. Dasari
United Scientific Group, LLC
408-426-4833
email us here